These findings may be attributed to the fact that although aberrant over-expression of the IR in breast cancer cells significantly increases the effects of insulin on such cells, IR over-expression causes a certain degree of insulin receptor saturation on the cell membrane. This evidence concerns the gene INS and breast carcinoma.